Michael H. Rowe
Box Hill Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael H. Rowe.
Journal of the American College of Cardiology | 1991
Tomoaki Hinohara; Michael H. Rowe; Gregory C. Robertson; Matthew R. Selmon; Lissa J. Braden; James Leggett; James W. Vetter; John B. Simpson
Directional coronary atherectomy, a new transluminal procedure for treatment of obstructive lesions in coronary arteries by excision and removal of tissue, was performed on 447 lesions in 382 procedures. Successful outcome, defined as a reduction of stenosis by greater than or equal to 20% with a less than 50% residual stenosis, was achieved in 89.5% of lesions and mean stenosis was reduced from 75.9 +/- 13.3% to 14.5 +/- 22.1% (p less than 0.001). Complications included vessel occlusion during the procedure, 2.4%; vessel occlusion after the procedure, 1.3%; new lesion, 0.5%; nonobstructive guiding catheter-induced dissection, 0.3%; perforation, 0.8%; distal embolization, 2.1%; Q wave myocardial infarction, 0.8% and non-Q wave myocardial infarction, 4.2%. Twelve patients (3.1%) required coronary artery bypass surgery for these complications. The atherectomy success rate was greater than 80% and the combined atherectomy and angioplasty success rate was greater than 90% for complex morphologic features such as eccentric lesions, lengthy lesions, lesions with abnormal contour, angulated lesions, ostial lesions and lesions with branch involvement. In the presence of calcific deposition, atherectomy success rate was 52% for primary lesions and 83% for restenosed lesions. Among angiographically complex lesions, calcium was the predictor for failed atherectomy (p less than 0.0001). In summary, directional coronary atherectomy is safe and effective for treatment of obstructive lesions in coronary arteries in selected cases. In particular, it achieves a high success rate in lesions with complex morphologic characteristics, such as eccentricity, abnormal contour and ostial involvement.
Journal of the American College of Cardiology | 1992
Tomoaki Hinohara; Gregory C. Robertson; Matthew R. Selmon; James W. Vetter; Michael H. Rowe; Lissa J. Braden; Bruce J. McAuley; Dennis J. Sheehan; John B. Simpson
OBJECTIVES This study evaluates the incidence of restenosis after successful directional coronary atherectomy and identifies risk factors for restenosis. BACKGROUND Directional coronary atherectomy has been shown to be a safe and effective treatment of obstructive coronary artery disease; however, information regarding restenosis is limited. METHODS Between October 1986 and December 1989, 289 patients with 332 lesions were successfully treated with directional coronary atherectomy and followed up prospectively. Clinical follow-up information was available for 98% and angiographic follow-up information was obtained for 82% at approximately 6 months, or earlier if symptoms recurred. Angiograms were quantitatively analyzed. Restenosis was defined as greater than 50% stenosis at the site of intervention. RESULTS Seventy-four percent of patients were either asymptomatic or clinically improved after the procedure. Thirty-two percent were subsequently treated by coronary artery bypass surgery (14%), percutaneous transluminal coronary angioplasty (4%) or repeat atherectomy (13%). Angiographic evidence of restenosis was observed in 42%. The restenosis rate in native coronary arteries was 31% for primary lesions and 28% and 49%, respectively, for lesions treated with one or two previous angioplasty procedures. The restenosis rate for saphenous vein grafts was 53% for primary lesions and 58% and 82%, respectively, for lesions treated with one or two previous angioplasty procedures. The median interval to angiographically documented restenosis was 133 days. A higher restenosis rate was associated with a saphenous vein graft, hypertension, a longer lesion (greater than or equal to 10 mm), a smaller vessel diameter (less than 3 mm), a noncalcified lesion and use of a smaller (6F) device. CONCLUSIONS Restenosis remains a limitation of directional coronary atherectomy. A subset of patients with larger vessels, shorter lesions or lesions treated with a larger (7F) device may have a more favorable outcome.
American Journal of Cardiology | 1990
Michael H. Rowe; Tomoaki Hinohara; Neal W. White; Gregory C. Robertson; Matthew R. Selmon; John B. Simpson
Directional coronary atherectomy is a new percutaneous transluminal technique for treating occlusive coronary artery disease. In this study, angiographic results (i.e., residual stenosis and angiographic evidence of postprocedure dissection) after directional coronary atherectomy and balloon angioplasty were compared. The atherectomy group consisted of 91 lesions in 83 consecutive patients who underwent either left anterior descending artery or right coronary artery atherectomy. The angioplasty group consisted of 91 lesions in 84 patients that were matched with the atherectomy lesions with respect to vessel and whether the lesion was a restenosis lesion. The mean preprocedure diameter stenosis was 76% in both groups as measured quantitatively with electronic calipers. After the procedure, the mean residual diameter stenosis of the atherectomy lesions was 13 +/- 17%, whereas for the angioplasty lesions it was 31 +/- 18% (p less than 0.001). Success rates in both groups were similar (94.5 and 93.4%, respectively). The incidence of postprocedure dissection was 11% in the atherectomy group and 37% in the angioplasty group (p less than 0.0001). Directional coronary atherectomy results in significantly improved postprocedure angiographic appearances due to significantly less severe residual stenosis and lower incidence of dissection.
International Journal of Cardiac Imaging | 1989
Paul G. Yock; David T. Linker; Neal W. White; Michael H. Rowe; Matthew R. Selmon; Gregory C. Robertson; Tomoaki Hinohara; John B. Simpson
This paper discusses the potential application of intravascular ultrasound imaging in the context of catheter-based atherectomy. The advantages and limitations of ultrasound in this application are discussed, and representative cases are presented.
American Journal of Cardiology | 2001
Andrew E. Ajani; Paul Maruff; Roderic Warren; David Eccleston; Ronald J.L. Dick; A. MacIsaac; Michael H. Rowe; Jeffrey Lefkovits
This study assesses the impact of early percutaneous coronary intervention in patients presenting with cardiogenic shock after acute myocardial infarction. Predictors of in-hospital death include the need for intubation, cardiopulmonary resuscitation, and angiographic failure; long-term outcomes at 2 years in hospital survivors are favorable.
Journal of the American College of Cardiology | 1991
Matthew R. Salmon; Tomoaki Hinohara; Gregory C. Robertson; Michael H. Rowe; James W. Vetter; Thomas C. Bartzokis; Lissa J. Braden; John B. Simpson
Journal of the American College of Cardiology | 1990
Tomoaki Hinohara; Michael H. Rowe; Mary Ellen Sipperly; Danna E. Johnson; Gregory C. Robertson; Matthew R. Selmon; James Leggett; John M. Simpson
Journal of the American College of Cardiology | 1991
James W. Vetter; John B. Simpson; Gregory C. Robertson; Matthew R. Selmon; Michael H. Rowe; Thomas C. Bartzokis; Lissa J. Braden; Tomoaki Hinohara
Journal of the American College of Cardiology | 1990
John M. Simpson; Michael H. Rowe; Gregory C. Robertson; Matthew R. Selmon; James W. Vetter; Lissa J. Braden; Tomoaki Hinohara
Journal of the American College of Cardiology | 1991
Tomoaki Hinohara; Matthew R. Selmon; Gregory C. Robertson; James W. Vetter; Michael H. Rowe; Thomas C. Bartzokis; Lissa J. Braden; John B. Simpson